<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05075746</url>
  </required_header>
  <id_info>
    <org_study_id>BHC-RCR-001</org_study_id>
    <nct_id>NCT05075746</nct_id>
  </id_info>
  <brief_title>Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses</brief_title>
  <official_title>Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bausch &amp; Lomb Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the performance of the enVista Toric 0.9D&#xD;
      vs non-Toric IOLs equivalent in subjects with mild pre-operative corneal astigmatism of less&#xD;
      than 1.0D.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The performance of the enVista Toric IOLs will be compared with that of enVista non-Toric&#xD;
      (spherical) IOL in patients with pre-op corneal astigmatism &lt;1.0D. At least 384 eyes (n= 192&#xD;
      per lens type) from 3-4 Canadian centers will be investigated.&#xD;
&#xD;
      This is a retrospective chart review for preoperative and postoperative data conducted at&#xD;
      least 4 weeks after IOL implantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean reduction in cylindrical power of the eye</measure>
    <time_frame>4 weeks after IOL implantation</time_frame>
    <description>Reduction in the cylindrical power of the eye is defined as the difference between the magnitudes of the preoperative keratometric cylinder and the residual refractive cylinder (referenced to the corneal plane).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">384</enrollment>
  <condition>Corneal Astigmatism</condition>
  <arm_group>
    <arm_group_label>enVista Toric 0.9D intra ocular lens</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>enVista non-Toric (spherical) intra ocular lens</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>enVista Toric</intervention_name>
    <description>enVista Toric IOL</description>
    <arm_group_label>enVista Toric 0.9D intra ocular lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>enVista non-Toric (spherical)</intervention_name>
    <description>enVista non-Toric (spherical) IOL</description>
    <arm_group_label>enVista non-Toric (spherical) intra ocular lens</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The performance of the enVista Toric IOLs will be compared with that of enVista non-Toric&#xD;
        (spherical) IOL in patients with pre-op corneal astigmatism &lt;1.0D. At least 384 eyes (n=&#xD;
        192 per lens type) from 3-4 Canadian centers will be investigated.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and Females subjects age 18 or older&#xD;
&#xD;
          -  Implant of enVista Toric IOL and/or enVista non-Toric (spherical) IOL in at least one&#xD;
             eye&#xD;
&#xD;
          -  Subjects that require either an enVista 0.9D Toric IOL or an enVista non-toric&#xD;
             (spherical) IOL as determined by the Barrett Toric Calculator&#xD;
             (https://ascrs.org/tools/barrett-toric-calculator)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of ocular comorbidities (e.g., dry eyes, retinal pathology, etc.),&#xD;
&#xD;
          -  Decreased BCDVA of 20/25 or worse&#xD;
&#xD;
          -  Excessive IOL rotation &gt; 10 degrees&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anya Loncaric</last_name>
    <role>Study Director</role>
    <affiliation>Bausch Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jenny Hledik</last_name>
    <phone>15033511248</phone>
    <email>Jenny.Hledik@Bauschhealth.com</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 30, 2021</study_first_submitted>
  <study_first_submitted_qc>September 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

